Prognostic Value of the New Prostate Cancer International Society of Urological Pathology Grade Groups-Reference-Cited by-同舟云学术

Prognostic Value of the New Prostate Cancer International Society of Urological Pathology Grade Groups

Published:2017-09-29 Issue: Volume:4 Page:
ISSN:2296-858X
Container-title:Frontiers in Medicine
language:
Short-container-title:Front. Med.

Author:

Offermann Anne,Hohensteiner Silke,Kuempers Christiane,Ribbat-Idel Julika,Schneider Felix,Becker Finn,Hupe Marie Christine,Duensing Stefan,Merseburger Axel S.,Kirfel Jutta,Reischl Markus,Lubczyk Verena,Kuefer Rainer,Perner Sven

Publisher

Frontiers Media SA

Subject

General Medicine

Reference22 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016

2. The complexity of prostate cancer: genomic alterations and heterogeneity;Boyd;Nat Rev Urol,2012

3. Prostate carcinoma II: prognostic factors in prostate needle biopsies;Montironi;BJU Int,2006

4. Prostate cancers scored as Gleason 6 on prostate biopsy are frequently Gleason 7 tumors at radical prostatectomy: implication on outcome;Pinthus;J Urol,2006

5. Interobserver reproducibility of Gleason grading of prostatic carcinoma: general pathologist;Allsbrook;Hum Pathol,2001

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Clinical Factors on 18F-Flotufolastat Detection Rates in Men With Recurrent Prostate Cancer: Exploratory Analysis of the Phase 3 SPOTLIGHT Study;Advances in Radiation Oncology;2024-08

2. Clinical and histopathological parameters in transrectal ultrasound‐guided biopsies associated with tumor upgrading after radical prostatectomy: A comparative analysis of risk groups;The Prostate;2024-05-27

3. The Association between Urine N-Glycome and Prognosis after Initial Therapy for Primary Prostate Cancer;Biomedicines;2024-05-08

4. Raman spectroscopy system for real‐time diagnosis of clinically significant prostate cancer tissue;Journal of Biophotonics;2023-02-12

5. Prognostic Utility of the Gleason Grading System Revisions and Histopathological Factors Beyond Gleason Grade;Clinical Epidemiology;2022-01